HealthTree Logo
search more_vert
close
person Sign In / Create Account
Today's CAR T Options in Multiple Myeloma Care with Luciano Costa, MD, UAB
Today's CAR T Options in Multiple Myeloma Care with Luciano Costa, MD, UAB image
HealthTree Podcast for Multiple Myeloma
event Oct 27, 2023 / 01:00PM CDT

Event Description

TO JOIN THE SHOW BY PHONE, PLEASE CALL 347-637-2631.

CAR T therapy is a highly effective treatment for myeloma patients, even in highly relapsed multiple myeloma. In today's show we will hear from Luciano Costa, MD of the University of Alabama at Birmingham who will do a deep dive into CAR T therapy in multiple myeloma to discuss how CAR T availability is improving, how CAR T is being tested in earlier lines of therapy, side effects to consider, new CAR T targets, combo CAR Ts, maintenance therapy post-CAR T, open CAR T clinical trials and various new forms CAR T variants like NK CAR Ts. Join us for this important show on one of the most impressive therapies ever developed in myeloma! 

Thanks to our episode sponsor, 

 

 


We appreciate your donations to support the HealthTree Podcast for Multiple Myeloma.

DONATE

Schedule & Agenda

The panelist Jennifer Ahlstrom
Welcome
12:00 PM
Jennifer Ahlstrom

Welcome, Announcements & Introduction

The panelist Luciano Costa, MD, PhD
Discussion with Dr. Costa
12:05 PM
Luciano Costa, MD, PhD

An extensive discussion about CAR T in multiple myeloma.

person
Q&A
12:50 PM
Audience

Audience is able to call in to the radio show. Call 347-637-2631 and press 1 on your keypad to ask Dr. Costa questions about what was discussed during our interview today.

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio
The panelist Luciano Costa, MD, PhD
Luciano Costa, MD, PhD

Luciano J. Costa, M.D., Ph.D., serves as the Associate Director for Clinical Research at the O’Neal Comprehensive Cancer Center at UAB. Dr. Costa obtained his M.D. and subsequently Ph.D. from Universidade de Sao Paulo, Brazil. He then trained in hematology and medical oncology at the University of Colorado in Aurora and in blood and marrow transplantation at the Mayo Clinic in Rochester, Minnesota. Prior to joining UAB, Dr. Costa was an Associate Professor of Medicine at the Medical University of South Carolina where he co-chaired the Protocol Review Committee at Hollings Cancer Center. He was recruited to the O’Neal Comprehensive Cancer Center in 2014 as a Senior Clinical Investigator and currently directs the Multiple Myeloma and the Immune Effector Cellular Therapy programs. His primary research focus is the development of new therapies for plasma cell malignancies. Dr. Costa leads several multi-institutional and international projects exploring new cellular and immunotherapies and minimal residual disease in myeloma. He is regarded as an international leader in the field with more than 200 peer-reviewed abstracts and publications in high-impact journals such as Blood, Leukemia, the Journal of Clinical Oncology and The New England Journal of Medicine.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Regeneron
Adaptive
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube